TABLE OF CONTENTS
Volume 67, Issue 6 (June 2005)
Perspectives in Renal Medicine |
Perspectives in Basic Science |
Hormones – Cytokines – Signalling |
Cell Biology – Immunology – Pathology |
Ion Channels – Membrane Transport – Integrative Physiology |
Vascular Biology – Hemodynamics – Hypertension |
Clinical Nephrology – Epidemiology – Clinical Trials |
Dialysis – Transplantation |
Technical Notes |
Editorials |
Letters to the Editor |
Nephrology Forum |
International Society of Nephrology |
Acknowledgment of Reviewers |
Author Index
New Initiative
Definition and classification of chronic kidney disease: A position statement from Kidney Disease: Improving Global Outcomes (KDIGO)
ANDREW S LEVEY, KAI-UWE ECKARDT, YUSUKE TSUKAMOTO, ADEERA LEVIN, JOSEF CORESH, JEROME ROSSERT, DICK DE ZEEUW, THOMAS H HOSTETTER, NORBERT LAMEIRE and GARABED EKNOYAN
Kidney Int 67: 2089-2100; doi:10.1111/j.1523-1755.2005.00365.x
Perspectives in Renal Medicine
Preeclampsia: A renal perspective
S ANANTH KARUMANCHI, SHARON E MAYNARD, ISAAC E STILLMAN, FRANKLIN H EPSTEIN and VIKAS P SUKHATME
Kidney Int 67: 2101-2113; doi:10.1111/j.1523-1755.2005.00316.x
Perspectives in Basic Science
Transcriptome analysis and kidney research: Toward systems biology
MINGYU LIANG, ALLEN W COWLEY JR, MARTIN J HESSNER, JOZEF LAZAR, DAVID P BASILE and JENNIFER L PIETRUSZ
Kidney Int 67: 2114-2122; doi:10.1111/j.1523-1755.2005.00315.x
Hormones – Cytokines – Signalling
Role of coagulation factor Xa and protease-activated receptor 2 in human mesangial cell proliferation
MISA TANAKA, HIDENORI ARAI, NING LIU, FUMIAKI NOGAKI, KEIKO NOMURA, KENJI KASUNO, EMI OIDA, TORU KITA and TAKAHIKO ONO
Kidney Int 67: 2123-2133; doi:10.1111/j.1523-1755.2005.00317.x
AT1R blockade reduces IFN-
production in lymphocytes in vivo and in vitro
JON A WEIDANZ, LYNN M JACOBSON, REBECCA J MUEHRER, ARJANG DJAMALI, DEBRA A HULLETT, JENIFER SPRAGUE, MAURIZIO CHIRIVA-INTERNATI, VAUGHAN WITTMAN, THOMAS J THEKKUMKARA and BRYAN N BECKER
Kidney Int 67: 2134-2142; doi:10.1111/j.1523-1755.2005.00318.x
Hepatocyte growth factor (HGF) modulates matrix turnover in human glomeruli
CIRO ESPOSITO, BINA PARRILLA, ANDREANA DE MAURI, FLAVIA CORNACCHIA, GIANLUCA FASOLI, ANNALISA FOSCHI, TIZIANA MAZZULLO, ANNARITA PLATI, ROBERTA SCUDELLARO and ANTONIO DAL CANTON
Kidney Int 67: 2143-2150; doi:10.1111/j.1523-1755.2005.00319.x
See also: Editorial by STRIKERRenal cyclooxygenase-2 in obese Zucker (fatty) rats
RADKO KOMERS, JANA 
DYCHOVÁ, MONIKA CAHOVÁ, LUDMILA KAZDOVÁ, JESSIE N LINDSLEY and SHARON ANDERSON
Kidney Int 67: 2151-2158; doi:10.1111/j.1523-1755.2005.00320.x
Cell Biology – Immunology – Pathology
Dendrimer-enhanced MRI as a diagnostic and prognostic biomarker of sepsis-induced acute renal failure in aged mice
JAMES W DEAR, HISATAKA KOBAYASHI, SANG-KYUNG JO, MIKAELA K HOLLY, XUZHEN HU, PETER S T YUEN, MARTIN W BRECHBIEL and ROBERT A STAR
Kidney Int 67: 2159-2167; doi:10.1111/j.1523-1755.2005.00321.x
T-cell transcriptome analysis points up a thymic disorder in idiopathic nephrotic syndrome
HICHAM MANSOUR, LYDIE CHEVAL, JEAN-MARC ELALOUF, JEAN-CHRISTOPHE AUDE, MARIA-ALEXANDRA ALYANAKIAN, BÉATRICE MOUGENOT, ALAIN DOUCET and GEORGES DESCHÊNES
Kidney Int 67: 2168-2177; doi:10.1111/j.1523-1755.2005.00322.x
DNA vaccination with naked DNA encoding MCP-1 and RANTES protects against renal injury in adriamycin nephropathy
HUILING WU, YIPING WANG, YUET-CHING TAY, GUOPING ZHENG, CHUN ZHANG, STEPHEN I ALEXANDER and DAVID C H HARRIS
Kidney Int 67: 2178-2186; doi:10.1111/j.1523-1755.2005.00323.x
Small bowel cyclooxygenase 2 (COX-2) expression in patients with IgA nephropathy
TEEMU HONKANEN, JUKKA MUSTONEN, HEIKKI KAINULAINEN, JUHANI MYLLYMÄKI, PEKKA COLLIN, MIKKO HURME and IMMO RANTALA
Kidney Int 67: 2187-2195; doi:10.1111/j.1523-1755.2005.00324.x
Triglyceride accumulation in injured renal tubular cells: Alterations in both synthetic and catabolic pathways
ALI C M JOHNSON, ANDREAS STAHL and RICHARD A ZAGER
Kidney Int 67: 2196-2209; doi:10.1111/j.1523-1755.2005.00325.x
Geranylgeranylacetone ameliorates ischemic acute renal failure via induction of Hsp70
SATOSHI SUZUKI, SHOICHI MARUYAMA, WAICHI SATO, YOSHIKI MORITA, FUMIHIKO SATO, YUSUKE MIKI, SAWAKO KATO, MASAHISA KATSUNO, GEN SOBUE, YUKIO YUZAWA and SEIICHI MATSUO
Kidney Int 67: 2210-2220; doi:10.1111/j.1523-1755.2005.00326.x
Multifunctionality of PAI-1 in fibrogenesis: Evidence from obstructive nephropathy in PAI-1–overexpressing mice
SHUNYA MATSUO, JESÚS M LÓPEZ-GUISA, XIAOHE CAI, DARYL M OKAMURA, CHARLES E ALPERS, ROGER E BUMGARNER, METTE A PETERS, GUOQIANG ZHANG and ALLISON A EDDY
Kidney Int 67: 2221-2238; doi:10.1111/j.1523-1755.2005.00327.x
See also: Editorial by HUANG & NOBLENephrin and podocin dissociate at the onset of proteinuria in experimental membranous nephropathy
TAKESHI NAKATSUE, HIROKO KOIKE, GI DONG HAN, KOICHI SUZUKI, NAOKO MIYAUCHI, HUAIPING YUAN, DAVID J SALANT, FUMITAKE GEJYO, FUJIO SHIMIZU and HIROSHI KAWACHI
Kidney Int 67: 2239-2253; doi:10.1111/j.1523-1755.2005.00328.x
Up-regulation of tissue factor activity on human proximal tubular epithelial cells in response to Shiga toxin
EIRINI NESTORIDI, RAFAIL I KUSHAK, DAYANA DUGUERRE, ERIC F GRABOWSKI and JULIE R INGELFINGER
Kidney Int 67: 2254-2266; doi:10.1111/j.1523-1755.2005.00329.x
Progression of secondary hyperparathyroidism involves deregulation of genes related to DNA and RNA stability
ÍÑIGO SANTAMARÍA, DANIEL ÁLVAREZ-HERNÁNDEZ, ROSA JOFRÉ, JOSÉ RAMÓN POLO, JAVIER MENÁRGUEZ and JORGE B CANNATA-ANDÍA
Kidney Int 67: 2267-2279; doi:10.1111/j.1523-1755.2005.00330.x
Ion Channels – Membrane Transport – Integrative Physiology
Impaired EDHF-mediated vasodilation and function of endothelial Ca2+-activated K+ channels in uremic rats
RALF KÖHLER, INES EICHLER, HERDIS SCHÖNFELDER, IVICA GRGIC, PHILIPP HEINAU, HAN SI and JOACHIM HOYER
Kidney Int 67: 2280-2287; doi:10.1111/j.1523-1755.2005.00331.x
Vascular Biology – Hemodynamics – Hypertension
The antioxidant N-acetylcysteine prevents accelerated atherosclerosis in uremic apolipoprotein E knockout mice
OGNEN IVANOVSKI, DOROTA SZUMILAK, THAO NGUYEN-KHOA, NADYA RUELLAN, OLIVIER PHAN, BERNARD LACOUR, BÉATRICE DESCAMPS-LATSCHA, TILMAN B DRÜEKE and ZIAD A MASSY
Kidney Int 67: 2288-2294; doi:10.1111/j.1523-1755.2005.00332.x
Role of calcification inhibitors in the pathogenesis of vascular calcification in chronic kidney disease (CKD)
SHARON M MOE, MARTINA RESLEROVA, MARKUS KETTELER, KALISHA O'NEILL, DANXIA DUAN, JACOB KOCZMAN, RALF WESTENFELD, WILLI JAHNEN-DECHENT and NEAL X CHEN
Kidney Int 67: 2295-2304; doi:10.1111/j.1523-1755.2005.00333.x
Validation of quantitative BOLD MRI measurements in kidney: Application to unilateral ureteral obstruction
MICHAEL PEDERSEN, THOMAS H DISSING, JAN MØRKENBORG, HANS STØDKILDE-JØRGENSEN, LARS H HANSEN, LARS B PEDERSEN, NICOLAS GRENIER and JØRGEN FRØKIAER
Kidney Int 67: 2305-2312; doi:10.1111/j.1523-1755.2005.00334.x
Clinical Nephrology – Epidemiology – Clinical Trials
Urine protein patterns can serve as diagnostic tools in patients with IgA nephropathy
MARION HAUBITZ, STEFAN WITTKE, EVA M WEISSINGER, MICHAEL WALDEN, HARALD D RUPPRECHT, JÜRGEN FLOEGE, HERMANN HALLER and HARALD MISCHAK
Kidney Int 67: 2313-2320; doi:10.1111/j.1523-1755.2005.00335.x
The Cockcroft-Gault formula should not be used in children
GUIDO FILLER, JENNIFER FOSTER, AMY ACKER, NATHALIE LEPAGE, AYUB AKBARI and JOCHEN H H EHRICH
Kidney Int 67: 2321-2324; doi:10.1111/j.1523-1755.2005.00336.x
Reduction of urinary connective tissue growth factor by Losartan in type 1 patients with diabetic nephropathy
STEEN ANDERSEN, FRANS A VAN NIEUWENHOVEN, LISE TARNOW, PETER ROSSING, KASPER ROSSING, LOTTE WIETEN, ROEL GOLDSCHMEDING and HANS-HENRIK PARVING
Kidney Int 67: 2325-2329; doi:10.1111/j.1523-1755.2005.00337.x
Prognostic value of combined use of biomarkers of inflammation, endothelial dysfunction, and myocardiopathy in patients with ESRD
FRANCESCA MALLAMACI, GIOVANNI TRIPEPI, SEBASTIANO CUTRUPI, LORENZO S MALATINO and CARMINE ZOCCALI
Kidney Int 67: 2330-2337; doi:10.1111/j.1523-1755.2005.00338.x
Parathyroid hormone and growth in children with chronic renal failure
SIMON C WALLER, DEBORAH RIDOUT, TOM CANTOR and LESLEY REES
Kidney Int 67: 2338-2345; doi:10.1111/j.1523-1755.2005.00339.x
The increased incidence of pure red cell aplasia with an Eprex formulation in uncoated rubber stopper syringes
KATIA BOVEN, SCOTT STRYKER, JOHN KNIGHT, ADRIAN THOMAS, MARC VAN REGENMORTEL, DAVID M KEMENY, DAVID POWER, JEROME ROSSERT and NICOLE CASADEVALL
Kidney Int 67: 2346-2353; doi:10.1111/j.1523-1755.2005.00340.x
Autosomal-dominant familial hematuria with retinal arteriolar tortuosity and contractures: A novel syndrome
EMMANUELLE PLAISIER, SONIA ALAMOWITCH, OLIVIER GRIBOUVAL, BÉATRICE MOUGENOT, ALAIN GAUDRIC, CORINNE ANTIGNAC, ETIENNE ROULLET and PIERRE RONCO
Kidney Int 67: 2354-2360; doi:10.1111/j.1523-1755.2005.00341.x
Regional citrate versus systemic heparin anticoagulation for continuous renal replacement in critically ill patients
DEMETRIOS J KUTSOGIANNIS, R T NOEL GIBNEY, DANIEL STOLLERY and JUN GAO
Kidney Int 67: 2361-2367; doi:10.1111/j.1523-1755.2005.00342.x
The effect of a first kidney transplant on a subsequent transplant outcome: An experimental and clinical study
DAVID LAIR, STÉPHANIE COUPEL, MAGALI GIRAL, MARYVONNE HOURMANT, GEORGES KARAM, CLAIRE USAL, JEAN DENIS BIGNON, SOPHIE BROUARD and JEAN-PAUL SOULILLOU
Kidney Int 67: 2368-2375; doi:10.1111/j.1523-1755.2005.00343.x
The association between benign prostatic hyperplasia and chronic kidney disease in community-dwelling men
ANDREW D RULE, DEBRA J JACOBSON, ROSEBUD O ROBERTS, CYNTHIA J GIRMAN, MICHAELA E MCGREE, MICHAEL M LIEBER and STEVEN J JACOBSEN
Kidney Int 67: 2376-2382; doi:10.1111/j.1523-1755.2005.00344.x
Low fetuin-A levels are associated with cardiovascular death: Impact of variations in the gene encoding fetuin
PETER STENVINKEL, KAI WANG, ABDUL RASHID QURESHI, JONAS AXELSSON, ROBERTO PECOITS-FILHO, PING GAO, PETER BARANY, BENGT LINDHOLM, TOMAS JOGESTRAND, OLOF HEIMBÜRGER, CLIFFORD HOLMES, MARTIN SCHALLING and LOUISE NORDFORS
Kidney Int 67: 2383-2392; doi:10.1111/j.1523-1755.2005.00345.x
Case-control study of regular analgesic and nonsteroidal anti-inflammatory use and end-stage renal disease
LUISA IBÁÑEZ, MÀRIUS MORLANS, XAVIER VIDAL, MARÍA JOSÉ MARTÍNEZ and JOAN-RAMON LAPORTE
Kidney Int 67: 2393-2398; doi:10.1111/j.1523-1755.2005.00346.x
Conversion of tunneled hemodialysis catheter–consigned patients to arteriovenous fistula
ARIF ASIF, GAUTAM CHERLA, DONNA MERRILL, CRISTIAN D CIPLEU, PATRICIA BRIONES and PHILLIP PENNELL
Kidney Int 67: 2399-2406; doi:10.1111/j.1523-1755.2005.00347.x
The advanced age deceased kidney donor: Current outcomes and future opportunities
Y MUN WOO, JOHN S GILL, NATHAN JOHNSON, BRIAN J G PEREIRA and SUNDARAM HARIHARAN
Kidney Int 67: 2407-2414; doi:10.1111/j.1523-1755.2005.00348.x
Dialysis – Transplantation
New onset hyperglycemia and diabetes are associated with increased cardiovascular risk after kidney transplantation
FERNANDO G COSIO, YOGISH KUDVA, MARIJE VAN DER VELDE, TIMOTHY S LARSON, STEPHEN C TEXTOR, MATTHEW D GRIFFIN and MARK D STEGALL
Kidney Int 67: 2415-2421; doi:10.1111/j.1523-1755.2005.00349.x
Rapamycin inhibits human renal epithelial cell proliferation: Effect on cyclin D3 mRNA expression and stability
NICOLAS PALLET, ERIC THERVET, DELPHINE LE CORRE, BERTRAND KNEBELMANN, PATRICK NUSBAUM, CÉLINE TOMKIEWICZ, PAUL MERIA, JEAN-PIERRE FLINOIS, PHILIPPE BEAUNE, CHRISTOPHE LEGENDRE and DANY ANGLICHEAU
Kidney Int 67: 2422-2433; doi:10.1111/j.1523-1755.2005.00350.x
Silent cerebral infarction predicts vascular events in hemodialysis patients
TOSHIHIDE NAGANUMA, JUNJI UCHIDA, KENJI TSUCHIDA, YOSHIAKI TAKEMOTO, SHINJI TATSUMI1, KAZUNOBU SUGIMURA and TATSUYA NAKATANI
Kidney Int 67: 2434-2439; doi:10.1111/j.1523-1755.2005.00351.x
AUC-guided dosing of tacrolimus prevents progressive systemic overexposure in renal transplant recipients
EDUARD M SCHOLTEN, SERGE C L M CREMERS, RIK C SCHOEMAKER, AJDA T ROWSHANI, ERIK J VAN KAN, JAN DEN HARTIGH, LEENDERT C PAUL and JOHAN W DE FIJTER
Kidney Int 67: 2440-2447; doi:10.1111/j.1523-1755.2005.00352.x
Access to, and outcome of, renal transplantation according to treatment modality of end-stage renal disease in France
YLANA CHALEM, JEAN-PHILIPPE RYCKELYNCK, PHILIPPE TUPPIN, CHRISTIAN VERGER, SYLVIE CHAUVÉ and DENIS GLOTZ F
Kidney Int 67: 2448-2453; doi:10.1111/j.1523-1755.2005.00353.x
Relevance of Toll-like receptor-4 polymorphisms in renal transplantation
DIDIER DUCLOUX, MARINA DESCHAMPS, MARIA YANNARAKI, CHRISTOPHE FERRAND, JAMAL BAMOULID, PHILIPPE SAAS, AMIR KAZORY, JEAN-MARC CHALOPIN and PIERRE TIBERGHIEN
Kidney Int 67: 2454-2461; doi:10.1111/j.1523-1755.2005.00354.x
Arteriovenous fistula outcomes in the era of the elderly dialysis population
CHARMAINE E LOK, MATTHEW J OLIVER, JIANDONG SU, CYNTHIA BHOLA, NEIL HANNIGAN and SARBJIT V JASSAL
Kidney Int 67: 2462-2469; doi:10.1111/j.1523-1755.2005.00355.x
Dialysate partitioning in the Genius® batch hemodialysis system: Effect of temperature and solute concentration
ANNEMIEKE DHONDT, SUNNY ELOOT, DIRK DE WACHTER, RITA DE SMET, MARIE-ANNE WATERLOOS, GRIET GLORIEUX, NORBERT LAMEIRE, PASCAL VERDONCK and RAYMOND VANHOLDER
Kidney Int 67: 2470-2476; doi:10.1111/j.1523-1755.2005.00356.x
Genetic and clinical factors influence the baseline permeability of the peritoneal membrane
GAËLLE GILLEROT, ERIC GOFFIN, CATHERINE MICHEL, PIETER EVENEPOEL, WIM VAN BIESEN, MICHEL TINTILLIER, PETER STENVINKEL, OLOF HEIMBÜRGER, BENGT LINDHOLM, LOUISE NORDFORS, ANNIE ROBERT and OLIVIER DEVUYST
Kidney Int 67: 2477-2487; doi:10.1111/j.1523-1755.2005.00357.x
Technical Notes
Antibodies against macrophages that overlap in specificity with fibroblasts
TSUTOMU INOUE, DAVID PLIETH, CHRISTO D VENKOV, CAROL XU and ERIC G NEILSON
Kidney Int 67: 2488-2493; doi:10.1111/j.1523-1755.2005.00358.x
Increased tubular organic ion clearance following chronic ACE inhibition in patients with type 1 diabetes
MERLIN C THOMAS, GEORGE JERUMS, CON TSALAMANDRIS, RICHARD MACISAAC, SIANNA PANAGIOTOPOULOS, MARK E COOPER and MDNSG S
Kidney Int 67: 2494-2499; doi:10.1111/j.1523-1755.2005.00359.x
Editorials
HGF and extracellular matrix turnover in normal human glomeruli ex vivo
GARY STRIKER
Kidney Int 67: 2500-2501; doi:10.1111/j.1523-1755.2005.00367.x
See also: Hormones – Cytokines – Signalling by ESPOSITO et al.An unexpected role of plasminogen activator inhibitor-type 1 (PAI-1) in renal fibrosis
YUFENG HUANG and NANCY NOBLE
Kidney Int 67: 2502-2503; doi:10.1111/j.1523-1755.2005.00368.x
See also: Cell Biology – Immunology – Pathology by MATSUO et al.Letters to the Editor
Neutrophil activation and renal scarring
NICHOLAS TOPLEY, ROBERT STEADMAN and JOHN D WILLIAMS
Kidney Int 67: 2504; doi:10.1111/j.1523-1755.2005.360_1.x
See also: Letter to the Editor by SVENSSON et al.Reply from the Authors
MAJLIS SVENSSON, H IRJALA, P ALM, B HOLMQVIST, A-C LUNDSTEDT and CATHARINA SVANBORG
Kidney Int 67: 2504-2505; doi:10.1111/j.1523-1755.2005.360_2.x
See also: Letter to the Editor by TOPLEY et al.Pharmacologic intervention to prevent hemodialysis vascular access thrombosis: The next generation of treatment?
CHARLES J DISKIN
Kidney Int 67: 2505; doi:10.1111/j.1523-1755.2005.360_3.x
Locking hemodialysis catheters with cefotaxime instead of gentamicin to avoid potential ototoxicity
ANIL K SAXENA and B R PANHOTRA
Kidney Int 67: 2505-2506; doi:10.1111/j.1523-1755.2005.00360.x
The differential impact of risk factors on mortality in hemodialysis and peritoneal dialysis
PETER J H SMAK GREGOOR
Kidney Int 67: 2506; doi:10.1111/j.1523-1755.2005.360_5.x
Prevention of renal cell carcinoma from hemodialysis patients by regulating epigenetic factors
SHIRAI SUMIKO, HAGIWARA HIROMI, SATO HIROMI, FUKUMOTO KEIKO, KOBAYASHI SHIGETO, SEKI TAIICHIRO, ARIGA TOYOHIKO, HAGIWARA KIYOKAZU, YAMASAKI HIROSHI and YANO TOMOHIRO
Kidney Int 67: 2506-2507; doi:10.1111/j.1523-1755.2005.360_6.x
Nephrology Forum
Bacterial infections in hemodialysis patients: Pathogenesis and prevention
BERTRAND L JABER Principal discussant:
Kidney Int 67: 2508-2519; doi:10.1111/j.1523-1755.2005.00364.x
International Society of Nephrology
International Society of Nephrology
Kidney Int 67: 2520-2523; doi:10.1111/j.1523-1755.2005.90676.x
Acknowledgment of Reviewers
Acknowledgment of Reviewers
Kidney Int 67: 2524-2528; doi:10.1111/j.1523-1755.2005.20050503.x
